相关实验视频
Updated: Jul 5, 2025

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.8K
德克索鲁比诱导的心脏毒性和危险因素
Carl Belger1, Carmelita Abrahams1, Aqeela Imamdin1
1Cardioprotection Group, Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
International journal of cardiology. Heart & vasculature
|January 15, 2024
概括
多克索鲁比 (DOX) 化疗可能会导致心脏损伤. 本综述研究了年龄,糖尿病和高血压等因素如何增加癌症患者中DOX诱导心脏毒性的风险.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- doxorubicin (DOX) 是一种重要的化疗药物,用于治疗各种癌症.
- 由于显著的心脏毒性,DOX治疗往往受到限制.
- 鉴定DOX诱导心脏毒性风险因素对于患者管理至关重要.
研究的目的:
- 审查当前关于DOX诱导心脏毒性的临床前和临床研究.
- 探索各种患者特异性风险因素对DOX心脏毒性的影响.
- 帮助为患有心血管风险的患者量身定制癌症治疗.
主要方法:
- 临床前研究的文献综述.
- 对临床研究结果的分析.
- 综合证据,将风险因素与DOX心脏毒性联系起来.
主要成果:
- 多种因素与DOX诱导心脏毒性的风险增加有关.
- 这些因素包括性别,年龄,种族,糖尿病,失脂症,肥胖,高血压,先前存在的心血管疾病和并发药物.
- 了解这些联系可以为临床决策提供信息.
结论:
- 在癌症治疗中,DOX诱导的心脏毒性是一个重大问题.
- 患者特定的风险因素在心脏毒性发展中发挥着关键作用.
- 对接受DOX治疗的癌症患者,特别是患有心血管风险因素的癌症患者,需要个性化治疗策略.
相关概念视频
Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
Exercise and Cardiovascular Response
815
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
815
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Pathophysiology of Cardiac Performance
665
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
665
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K

